The GREENFUND - we're buying the dip, big time, and here's why., page-39

“In the US that separation was not big and that’s what caused the difference in the abnormality we saw in the inflammatory arm. You’re getting an efficacy effect it’s just in the one arm of the vehicles that we had it was unusually high and only in the US.
Why was that, what’s the reason for that?
Again, I think we’re attributing it to 11 batches that we ran, potentially something went awry in the manufacturing of the vehicle arm only in the US when it was done and mainly due to its start up mode and doing everything really for the first time in the country.”

Rusty, my gripe concerns the above quote from Vince. Vince's best explanation (given in bold) is nonsensical and insulting to any thinking human being, unless, as we have been discussing, the term manufacturing encompasses the preparation and labelling of the subject individual potions.

If Vince had said “potentially something went awry in the preparation or labelling of the vehicle arm”, rather than using the term “manufacturing”, I would be very happy.

perhaps the whole issue is just a mis-communication, a misunderstanding of a technical term. I hope so. I don’t want to think that Vince is a dill or is just saying any old thing that he hopes will placate the market and us peon shareholders.

..

so, can anyone confirm whether the term “manufacture” includes the doling out into individual portions and the labelling of those portions?

@Southoz ???